Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 7Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Gliosarcoma 5Polycythemia Vera 4Meningioma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Neoplasms 3Leukemia 3Laryngeal Neoplasms 3Glioma 3Thrombocythemia, Essential 2Primary Myelofibrosis 2Pharyngeal Neoplasms 2Paranasal Sinus Neoplasms 2Myelodysplastic Syndromes 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Squamous Cell 2Tongue Neoplasms 1Thrombosis 1Thrombocytosis 1Stomach Neoplasms 1Salivary Gland Neoplasms 1Recurrence 1Polycythemia 1Papillomavirus Infections 1

Interventions

Radiation 1Paclitaxel 1Hydroxyurea 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × HPV-Negative Squamous Cell Carcinoma × Hydroxyurea × Clear all
NCT06005324 2025-06-08

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

University of Chicago

Phase 1 Recruiting
36 enrolled

HPV-Negative Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡